Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide as Primary Systemic Treatment in Elderly Breast Cancer Patients
Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.04.5773
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2006
Authors
Publisher
American Society of Clinical Oncology (ASCO)